Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-14
2010-02-02
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S333000, C514S300000, C514S309000, C546S122000, C546S141000
Reexamination Certificate
active
07655664
ABSTRACT:
The invention provides compounds of formula (I): wherein R1, R2, A, A1and B are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.
REFERENCES:
patent: 2327890 (1943-08-01), Henze
patent: 2745875 (1956-05-01), Ehrhart et al
patent: 3452040 (1969-06-01), Langis
patent: 3529019 (1970-09-01), Suh et al.
patent: 3849574 (1974-11-01), Suh et al.
patent: 4241073 (1980-12-01), Jamieson et al.
patent: 4315031 (1982-02-01), Vincent et al.
patent: 4983771 (1991-01-01), Bryker et al.
patent: 5068187 (1991-11-01), Takeichi et al.
patent: 5246943 (1993-09-01), Blankley et al.
patent: 5308853 (1994-05-01), Hodges et al.
patent: 5521187 (1996-05-01), Freyne et al.
patent: 5804593 (1998-09-01), Warpehoski et al.
patent: 5919790 (1999-07-01), Allen et al.
patent: 5955435 (1999-09-01), Baxter et al.
patent: 6046214 (2000-04-01), Kristiansen et al.
patent: 6048841 (2000-04-01), Baxter et al.
patent: 6114361 (2000-09-01), Robinson et al.
patent: 6159995 (2000-12-01), Thorwart et al.
patent: 6166041 (2000-12-01), Cavalla et al.
patent: 6218418 (2001-04-01), Pevarello et al.
patent: 6268379 (2001-07-01), Xue et al.
patent: 6277987 (2001-08-01), Kukkola et al.
patent: 6291685 (2001-09-01), Junghans et al.
patent: 6329418 (2001-12-01), Cheng et al.
patent: 6339101 (2002-01-01), Ross et al.
patent: 6340691 (2002-01-01), Levin et al.
patent: 6429213 (2002-08-01), Xue et al.
patent: 6890915 (2005-05-01), Sheppeck et al.
patent: 6906053 (2005-06-01), Sheppeck et al.
patent: 7078424 (2006-07-01), Hamilton et al.
patent: 7132434 (2006-11-01), Eriksson et al.
patent: 7354940 (2008-04-01), Henriksson et al.
patent: 7368465 (2008-05-01), Eriksson et al.
patent: 7427631 (2008-09-01), Eriksson et al.
patent: 2002/0006920 (2002-01-01), Robinson et al.
patent: 2002/0028835 (2002-03-01), Hu et al.
patent: 2002/0065219 (2002-05-01), Naidu et al.
patent: 2002/0091107 (2002-07-01), Madar et al.
patent: 2003/0130273 (2003-07-01), Sheppeck et al.
patent: 2004/0044215 (2004-03-01), Alcade et al.
patent: 2004/0106659 (2004-06-01), Af Rosenschold
patent: 2004/0110809 (2004-06-01), Lepisto et al.
patent: 2004/0116486 (2004-06-01), Lepisto et al.
patent: 2004/0127528 (2004-07-01), Eriksson et al.
patent: 2004/0138276 (2004-07-01), Eriksson et al.
patent: 2004/0147573 (2004-07-01), Eriksson et al.
patent: 2004/0152697 (2004-08-01), Chan et al.
patent: 2004/0209874 (2004-10-01), Sheppeck et al.
patent: 2004/0266832 (2004-12-01), Li et al.
patent: 2005/0019994 (2005-01-01), Chang
patent: 2005/0026990 (2005-02-01), Eriksson et al.
patent: 2005/0171096 (2005-08-01), Sheppeck et al.
patent: 2005/0256176 (2005-11-01), Burrows et al.
patent: 2006/0063818 (2006-03-01), Burrows et al.
patent: 2006/0276524 (2006-12-01), Henriksson et al.
patent: 2008/0004317 (2008-01-01), Gabos et al.
patent: 2008/0032997 (2008-02-01), Gabos et al.
patent: 2008/0064710 (2008-03-01), Gabos et al.
patent: 2008/0171882 (2008-07-01), Eriksson et al.
patent: 2008/0221139 (2008-09-01), Chapman et al.
patent: 2008/0262045 (2008-10-01), Eriksson et al.
patent: 2008/0293743 (2008-11-01), Gabos et al.
patent: 2008/0306065 (2008-12-01), Eriksson et al.
patent: 2009/0054659 (2009-02-01), Cornwall et al.
patent: 0175312 (1986-03-01), None
patent: 212617 (1986-08-01), None
patent: 0255390 (1988-02-01), None
patent: 0442584 (1991-08-01), None
patent: 0486280 (1991-11-01), None
patent: 0580210 (1994-01-01), None
patent: 0640594 (1995-03-01), None
patent: 0709375 (1995-10-01), None
patent: 0909754 (1999-04-01), None
patent: 1149843 (2001-10-01), None
patent: 1191024 (2002-03-01), None
patent: 1117616 (2003-04-01), None
patent: 02 74 1724 (2004-03-01), None
patent: 1550725 (2005-07-01), None
patent: WO 92/01062 (1992-01-01), None
patent: WO 95/14025 (1995-05-01), None
patent: WO 96/21640 (1996-07-01), None
patent: WO 96/27583 (1996-09-01), None
patent: WO 98/50359 (1998-05-01), None
patent: WO 99/06361 (1999-02-01), None
patent: WO 99/42443 (1999-02-01), None
patent: WO 99/24399 (1999-05-01), None
patent: WO 00/09103 (1999-08-01), None
patent: WO 00/35886 (1999-12-01), None
patent: WO 99/62880 (1999-12-01), None
patent: WO 00/12477 (2000-03-01), None
patent: WO 00/12478 (2000-03-01), None
patent: WO 00/40577 (2000-07-01), None
patent: WO00/44770 (2000-08-01), None
patent: WO 00/75106 (2000-12-01), None
patent: WO 01/05756 (2001-01-01), None
patent: WO 01/12189 (2001-02-01), None
patent: WO 01/22363 (2001-03-01), None
patent: WO 01/34573 (2001-05-01), None
patent: WO 02/06232 (2002-01-01), None
patent: WO 02/14262 (2002-02-01), None
patent: WO 02/14354 (2002-02-01), None
patent: WO 02/20515 (2002-02-01), None
patent: WO 02/074748 (2002-09-01), None
patent: WO 02/074749 (2002-09-01), None
patent: WO 02/074750 (2002-09-01), None
patent: WO 02/074751 (2002-09-01), None
patent: WO 02/074752 (2002-09-01), None
patent: WO 02/074767 (2002-09-01), None
patent: WO 02/096426 (2002-12-01), None
patent: WO 03/040098 (2003-05-01), None
patent: WO 03/087057 (2003-10-01), None
patent: WO 03/093260 (2003-11-01), None
patent: WO 03/094919 (2003-11-01), None
patent: WO 2004/020415 (2004-03-01), None
patent: WO 2004/024060 (2004-03-01), None
patent: WO 2004/024698 (2004-03-01), None
patent: WO 2004/024715 (2004-03-01), None
patent: WO 2004/024718 (2004-03-01), None
patent: WO 2004/024721 (2004-03-01), None
patent: WO 2004/033632 (2004-04-01), None
patent: WO 2004/108086 (2004-12-01), None
patent: WO2006/004532 (2006-01-01), None
patent: WO2006/004533 (2006-01-01), None
patent: WO 2006/065215 (2006-06-01), None
patent: WO 2006/065216 (2006-06-01), None
patent: WO 2006/077387 (2006-07-01), None
patent: WO 2007/106021 (2007-09-01), None
patent: WO 2007/106022 (2007-09-01), None
Rasmussen et al., Matrix Metalloproteinase Inhibition as a novel anticancer strategy, Pharmacol. Ther., vol. 75, No. 1, pp. 69-75, 1997.
Avgeropoulos et al., New Treatment Strategies for Malignant Gliomas, The Oncologist, 4:209-224, 1999.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1010, 1996.
Catterall et al., Drugs in development: bisphosphonates and metalloproteinase inhibitors, Arthritis Research and Therapy, vol. 5, No. 1, pp. 12-24, 2003.
Visse et al., Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases, Circulation Research, 92:827-839, 2003.
Chambers et al., Changing views of the role of Matrix Metalloproteinases in Metastasis, Journal of the National Cancer Institute, vol. 89, No. 17, Sep. 1997.
Morris et al., PubMed Abstract (Sequential Steps in Hematogenous Metastasis of Cancer Cells Studied by in vivo Videomicroscopy, Invasion Metastasis, 17:281-296) 1997.
Aharony et al. “Pharmacological Characterization of a New Class of Nonpeptide Neurokinin A Antagonists that Demonstrate Species Selectivity.” J. Pharmacol. Exp. Ther. 274:3 (1995), pp. 1216-1221.
Aimoto et al. “Synthesis of Carriers of Differing Strokes Radius with Activated Acyl Groups for Use as Reagents in Labeling Membrane Proteins.” Journal of Biological Chemistry, vol. 256(10), pp. 5134-5143, 1981.
Chemical Abstracts, vol. 65, 1966, Abstract No. 13684 h, M. Lora-Tamayo et al.: “Potential anticancer agents. I. Glutamine sulfonate analogs”, & Anales Real Soc. Espan. Fis. Quim (Madrid), Ser. B. 62(2), 173-86.
Croce, P. et al. “Stereoselective aldol addition of a chirai glycine enloate synthon to heteroaromatic aldehydes.” Heterocycles, 52:3 (2000) pp. 1337-1344.
Knabe, J. “Razemate und enantiomere basisch substituierter 5-phenylhydantoine.” Pharmazie. 52:12 (1997) pp. 912-919.
Bright et al. “Monoclonal Antibodies as Surrogate Receptors in High Throughput Screen for Compounds that Enhance Insulin Sensitivity.” Life Sciences. 61:23 (1997), pp. 2305-2315.
Lora-Tamayo et al. “anticancerousos Potenciales.” An. Quim. 64:6 (1968), pp. 591-606.
Michaelides et al., “Recent Advances in Matrix Metalloprotei
Af Rosenschold Magnus Munck
Gabos Balint
Lundkvist Michael
Shamovsky Igor
Zlatoidsky Pavol
AstraZeneca AB
Fish & Richardson P.C.
Rao Deepak
LandOfFree
Hydantoin derivatives as metalloproteinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydantoin derivatives as metalloproteinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoin derivatives as metalloproteinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4235299